Active Ingredient History
Iopamidol is a nonionic, low-osmolar iodinated contrast agent. Iopamidol is indicated for angiography, pediatric angiocardiography, selective visceral arteriography and aortography, peripheral venography, and adult and pediatric intravenous excretory urography and intravenous adult and pediatric contrast enhancement of computed tomographic. Renal toxicity has been reported in a few patients with liver dysfunction who were given oral cholecystographic agents followed by intravascular contrast agents. Intravascular injection of contrast media is frequently associated with the sensation of warmth and pain especially in peripheral arteriography and venography. In angiocardiography the adverse reactions are: hot flashes, angina pectoris, flushing, bradycardia, hypotension, hives. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Acute Kidney Injury (Phase 4)
Aortic Aneurysm, Thoracic (Phase 4)
Arterial Occlusive Diseases (Phase 4)
Body Weight (Phase 4)
Breast Neoplasms (Phase 1)
Carcinoma, Renal Cell (Early Phase 1)
Carcinoma, Transitional Cell (Early Phase 1)
Cervical Intraepithelial Neoplasia (Phase 4)
Contrast Media (Phase 4)
Coronary Artery Disease (Phase 2)
Coronary Disease (Phase 3)
Coronary Stenosis (Phase 4)
Diabetes Mellitus (Phase 4)
Healthy Volunteers (Phase 1/Phase 2)
Hypothyroidism (Phase 4)
Intestinal Neoplasms (Phase 4)
Kidney Diseases (Phase 4)
Percutaneous Coronary Intervention (Phase 4)
Prostatic Neoplasms, Castration-Resistant (Early Phase 1)
Pulmonary Embolism (Phase 4)
Renal Insufficiency (Phase 4)
Renal Insufficiency, Chronic (Phase 4)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
